GlassScriptPrepare for your visit
Zaffar Iqbal
Internal Medicine · Kingman, AZ · NPI 1316137169
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$921.39
in general payments reported to CMS, 2019-2025 · $137 in 2025
The $137 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Who reported paying
General payments only, top 6 by amount.
- Astellas Pharma US INC $143.35
- E.R. Squibb & Sons, L.L.C. $140.60
- Amgen INC. $81.61
- Medtronic, INC. $74.57
- Endogastric Solutions, INC $67.11
- Alnylam Pharmaceuticals INC. $62.27
Drugs and devices associated with these payments
Camzyos Veozah Bravo Esophyx Korlym Dexcom G6 Transmitter Krystexxa Afrezza Otezla Repatha Givlaari Myrbetriq
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Zaffar Iqbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/241305/zaffar-iqbal